Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Research output: Contribution to journal › Letter › Contributed › peer-review

Contributors

  • Joseph R. Berger - , University of Kentucky (Author)
  • Diego Centonze - , University of Rome Tor Vergata (Author)
  • Giancarlo Comi - , Vita-Salute San Raffaele University (Author)
  • Christian Confavreux - , Hôpital neurologique et neurochirurgical Pierre Wertheimer (Author)
  • Gary Cutter - , University of Alabama at Birmingham (Author)
  • Gavin Giovannoni - , Barts Health NHS Trust (Author)
  • Ralf Gold - , Ruhr University Bochum (Author)
  • Hans Peter Hartung - , Heinrich Heine University Düsseldorf (Author)
  • Fred Lublin - , Icahn School of Medicine at Mount Sinai (Author)
  • Augusto Miravalle - , University of Colorado Denver (Author)
  • Xavier Montalban - , Autonomous University of Barcelona (Author)
  • Paul O'Connor - , University of Toronto (Author)
  • Tomas Olsson - , Karolinska Institutet (Author)
  • Chris H. Polman - , Vrije Universiteit Amsterdam (VU) (Author)
  • Olaf Stuve - , University of Texas Southwestern Medical Center (Author)
  • Jerry S. Wolinsky - , University of Texas Health Science Center at Houston (Author)
  • Tjalf Ziemssen - , Department of Neurology (Author)

Details

Original languageEnglish
Pages (from-to)409-411
Number of pages3
JournalAnnals of neurology
Volume68
Issue number3
Publication statusPublished - Sept 2010
Peer-reviewedYes

External IDs

PubMed 20818795
ORCID /0000-0001-8799-8202/work/171553490

Keywords

ASJC Scopus subject areas